TGFB1 and idiopathic pulmonary fibrosis: In addition, T-cells among IPF patients show increased extents of prior activation, enhanced production of various inflammatory and/or pro-fibrotic mediators (e.g., TGF-β1), and impaired regulatory (Treg) function [10]–[14], [17].